🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Recruitingn/aAges 30 Years - anyFemaleMassachusetts General Hospital
NCT04794322 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims to develop a test for early detection of ovarian cancer using DNA from a growth involving the ovary found in a washing of the uterus (womb), and proteins found in the blood. The samples of the wash and the blood will be taken before surgery. After surgery, doctors will determine whether the participant had ovarian cancer or a benign disease of the ovaries. The tests of the washings and the blood will be examined to see how much the participants with ovarian cancer can be separated from the participants with a benign ovarian disease by the tests. Small amounts from the washing and the blood samples will be sent to four sites for analysis. Statistical analyses of these data will compare tumor DNA found in the washing of the uterus with proteins in the blood to detect cases of ovarian cancer. The primary goal is to find tests that are mostly positive for cases of ovarian can

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Has intact uterus (no history of uterine ablation, tubal ligation or bilateral salpingectomy) * Cohort 1 (n=200 participants): Women scheduled for surgery or diagnostic laparoscopy for suspected but undiagnosed ovarian/fallopian tube cancer * Cohort 2 (n=50 participants): Known BRCA1 or BRCA2 mutation carrier scheduled for risk-reducing salpingo-oophorectomy Exclusion Criteria: * Current tissue or cytology diagnostic procedure positive for ovary cancer or any cancer * Inability to provide informed consent * Age less than 30 years * Inability to obtain the minimum amount of blood * Inability to obtain the minimum amount of uterine lavage sample * At risk if blood were drawn (e.g. hemophilia, serious anemia- Hb less than 8.0 gm/dL) * Prior history of known ovarian or endometrial cancer * Treatment less than 1 year (excluding hormonal therapy) for cancer that spread beyond its origin * History of untreated high-grade cervical dysplasia (CIN3) * History of treated high grade cervical dysplasia (CIN3) with a cytologically abnormal pap smear within the past year. If there is no post treatment Pap smear in the medical record, perform a Pap smear prior to the day of surgery. If this Pap smear is abnormal, the participant is ineligible. * Currently pregnant * Known Lynch syndrome
💊

What it tests

  • Uterine lavage, or a wash of the womb
  • Blood sample
  • Pap smear
📍

Where

6 sites
University of Arkansas for Medical Sciences
Little Rock, United States
Kaiser Permanente - San Francisco
San Francisco, United States
Anne Arundel Health System
Annapolis, United States
Johns Hopkins University School of Medicine
Baltimore, United States
Massachusetts General Hospital
Boston, United States
The Swedish Hospital
Seattle, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy